{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:00:33Z","timestamp":1792548033293,"version":"4.5.0"},"reference-count":84,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:00:00Z","timestamp":1543363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["T32 ES007060-31A1"],"award-info":[{"award-number":["T32 ES007060-31A1"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Husson University School of Pharmacy","award":["2013-01"],"award-info":[{"award-number":["2013-01"]}]},{"DOI":"10.13039\/100008591","name":"Fahs-Beck Fund for Research and Experimentation","doi-asserted-by":"publisher","award":["2017-01"],"award-info":[{"award-number":["2017-01"]}],"id":[{"id":"10.13039\/100008591","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206100","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T18:32:32Z","timestamp":1543429952000},"page":"e0206100","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":140,"title":["Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2295-445X","authenticated-orcid":true,"given":"Brian J.","family":"Piper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy L.","family":"Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olapeju M.","family":"Simoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3138-4145","authenticated-orcid":true,"given":"Daniel Y.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Caggiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"McCall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,11,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","article-title":"Trends in the parent-report of health care provider diagnosed and medicated ADHD: United States, 2003\u20132011","volume":"53","author":"SN Visser","year":"2014","journal-title":"J Am Acad Child Adoles Psychiatry"},{"issue":"44","key":"ref2","first-page":"1439","article-title":"Increasing prevalence of parent-reported attention-deficit\/hyperactivity disorder among children\u2014United States, 2003 and 2007","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00004583-199907000-00008","article-title":"Are stimulants overprescribed? Treatment of ADHD in four U.S. communities","volume":"38","author":"PS Jensen","year":"1999","journal-title":"J Am Acad Child Adoles Psychiatry"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distribution of DSM-IV disorders in the National Comorbidy Survey replication","volume":"62","author":"RC Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.2006.163.4.716","article-title":"The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey replication","volume":"163","author":"RC Kessler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/15374416.2017.1417860","article-title":"Prevalence of parent-reported ADHD diagnosis and associated treatment among U.S. children and adolescents, 2016","volume":"47","author":"M Danielson","year":"2016","journal-title":"J Clin Child Adolesc Psychol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e1001190","DOI":"10.1371\/journal.pmed.1001190","article-title":"A comparison of DSM-IV and DSM-5 panel member\u2019s financial associations with industry: A pernicious problem persists","volume":"9","author":"L Cosgrove","year":"2012","journal-title":"PLoS Med"},{"key":"ref8","year":"2013"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.15585\/mmwr.mm6702a3","article-title":"Attention-Deficit\/Hyperactivity disorder medication prescription claims among privately insured women aged 15\u201344 years\u2013United States, 2003\u20132015","volume":"67","author":"KN Anderson","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1542\/peds.2011-2879","article-title":"Trends of outpatient prescription drug utilization in US children, 2002\u20132010","volume":"130","author":"G Chai","year":"2012","journal-title":"Pediatrics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-6-6","article-title":"Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs","volume":"6","author":"DD Han","year":"2006","journal-title":"BMC Pharmacol"},{"key":"ref12","first-page":"1","article-title":"ADHD: Clinical practice guideline for the evaluation for the diagnosis, evaluation, and treatment of Attention-Deficit Hyperactivity Disorder in children and adolescents","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"ref13","unstructured":"National Institute for Health Care Excellence (2018) Attention deficit hyperactivity disorder: Diagnosis and management. Accessed 3\/31\/2018 at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nice.org.uk\/guidance\/ng87\/resources\/attention-deficit-hyperactivity-disorder-diagnosis-and-management-pdf-1837699732933\" xlink:type=\"simple\">https:\/\/www.nice.org.uk\/guidance\/ng87\/resources\/attention-deficit-hyperactivity-disorder-diagnosis-and-management-pdf-1837699732933<\/ext-link>"},{"key":"ref14","first-page":"423","article-title":"Off-label prescribing trends for ADHD medications in very young children","volume":"22","author":"SG Panther","year":"2017","journal-title":"J Pediatric Pharmacol Ther"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.euroneuro.2017.03.002","article-title":"Trends in ADHD medication use in children and adolescents in five western countries, 2005\u20132012","volume":"27","author":"CJ Bachmann","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11","key":"ref16","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)","author":"OJ Storeb\u00f8","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref17","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents","author":"S Punja","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/ebmed-2017-110716","article-title":"The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder","volume":"22","author":"K Boesen","year":"2017","journal-title":"Evidence Based Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1542\/peds.2008-1597","article-title":"Positive association between attention-deficit\/hyperactivity disorder medication use and academic achievement during elementary school","volume":"123","author":"RM Scheffler","year":"2009","journal-title":"Pediatrics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.socscimed.2014.10.019","article-title":"The impending globalization of ADHD: Notes on the expansion and grown of a medicalized disorder","volume":"122","author":"P Conrad","year":"2014","journal-title":"Soc Sci Med"},{"key":"ref21","first-page":"1","article-title":"Attention Deficit Hyperactivity Disorder (ADHD): Controversy developmental mechanisms, and multiple levels of analysis","volume":"14","author":"SP Hinshaw","year":"2018","journal-title":"Ann Rev Psych"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.288.14.1740","article-title":"Developmental trajectories of brain volume abnormalities in children and adolescents with Attention-Deficit\/Hyperactivity Disorder","volume":"288","author":"FX Castellanos","year":"2002","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ajmg.b.32335","article-title":"Heritability of attention-deficit hyperactivity disorder in adults","volume":"168","author":"I Brikell","year":"2015","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ntt.2014.05.003","article-title":"Exposure to neurotoxicants and the development of attention deficit hyperactivity disorder and its related behaviors in childhood","volume":"44","author":"K Yolton","year":"2014","journal-title":"Neurotoxicol Teratol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e20171645","DOI":"10.1542\/peds.2017-1645","article-title":"Attention-Deficit\/Hyperactivity Disorder and very preterm\/very low birth weight: A meta-analysis","volume":"141","author":"AP Franz","year":"2018","journal-title":"Pediatrics"},{"issue":"4","key":"ref26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.acap.2016.08.013","article-title":"Associations between adverse childhood experiences and ADHD diagnoses and severity","volume":"17","author":"NM Brown","year":"2017","journal-title":"Acad Pediatr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1746-1561.2005.tb06685.x","article-title":"Sleep and student performance at school","volume":"75","author":"H Taras","year":"2005","journal-title":"J Sch Health"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jhealeco.2011.01.007","article-title":"School accountability laws and the consumption of psychostimulants","volume":"30","author":"FAS Bokhari","year":"2011","journal-title":"J Health Economics"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1176\/appi.ps.201400145","article-title":"State variation in increased ADHD prevalence: Links to NCLB school accountability and state medication laws","volume":"66","author":"BD Fulton","year":"2015","journal-title":"Psychiatr Serv"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12402-012-0085-3","article-title":"Stigma in attention deficit hyperactivity disorder","volume":"4","author":"AK Mueller","year":"2012","journal-title":"Atten Def Hyperact Disord"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ntr\/ntr181","article-title":"Executive function profile in the offspring of women that smoked during pregnancy","volume":"14","author":"BJ Piper","year":"2012","journal-title":"Nicotine Tob Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jamapediatrics.2016.4086","article-title":"Spending on children\u2019s personal health care in the United States, 1996\u20132013","volume":"171","author":"AL Bui","year":"2017","journal-title":"JAMA Pediatrics"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0033354917735548","article-title":"Medicaid prior authorization policies for medication treatment of Attention-Deficit\/Hyperactivity Disorder in young children, United States, 2015","volume":"132","author":"RL Hulkower","year":"2071","journal-title":"Public Health Rep"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1089\/cap.2016.0196","article-title":"Treated prevalence of Attention-Deficit\/Hyperactivity disorder increased from 2009 to 2015 among school-aged children and adolescents in the United States","volume":"27","author":"KA Nyarko","year":"2017","journal-title":"J Child Adoles Psychopharm"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1377\/hlthaff.26.2.450","article-title":"The global market for ADHD medications","volume":"26","author":"RM Scheffler","year":"2007","journal-title":"Health Affairs"},{"key":"ref36","first-page":"20073","article-title":"State-based and demographic variation in parent-reported medication rates for Attention-Deficit\/Hyperactivity Disorder, 2007\u20132008","volume":"10","author":"SN Visser","year":"2013","journal-title":"Prev Chron Dis"},{"key":"ref37","first-page":"141","article-title":"ADHD in Germany: Trends in diagnosis and pharmacotherapy","volume":"114","author":"CJ Bachman","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/CHI.0b013e318179963c","article-title":"Longitudinal mental health service and medication use for ADHD among Puerto Rican youth in two contexts","volume":"47","author":"HR Bird","year":"2008","journal-title":"J Am Acad Child Adoles Psychiatry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/070674371205700206","article-title":"Prevalence of prescribed Attention-Deficit Hyperactivity Disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994\u20132007","volume":"57","author":"MC Brault","year":"2012","journal-title":"Can J Psychiatry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.15585\/mmwr.mm6517e1","article-title":"Vital signs: National and state-specific patterns of Attention Deficit\/Hyperactivity Disorder treatment among insured children aged 2\u20135 years\u2013United States, 2008\u20132014","volume":"65","author":"SN Visser","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12888-016-1187-9","article-title":"Prevalence of attention deficit\/hyperactivity disorder among children and adolescents in China: A systematic review and meta-analysis","volume":"17","author":"T Wang","year":"2017","journal-title":"BMC Psychiatry"},{"key":"ref42"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amepre.2018.01.034","article-title":"Trends in medical use of opioids in the U.S., 2006\u20132016","volume":"54","author":"BJ Piper","year":"2018","journal-title":"Am J Prev Med"},{"key":"ref44","unstructured":"Stettin, 2018. Express scripts 2017 drug trend report. Accessed 3\/24\/18 at: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/lab.express-scripts.com\/lab\/drug-trend-report\/2017-dtr\" xlink:type=\"simple\">http:\/\/lab.express-scripts.com\/lab\/drug-trend-report\/2017-dtr<\/ext-link>"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1176\/appi.ps.201600469","article-title":"Racial-ethnic differences in patterns of discontinuous medication treatment among Medicaid-insured youths with ADHD","volume":"69","author":"X Ji","year":"2018","journal-title":"Psychiatr Serv"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1377\/hlthaff.2015.1423","article-title":"Ten-year trends in treatment services for children with Attention Deficit Hyperactivity Disorder (ADHD) enrolled in Medicaid","volume":"35","author":"KE Hoagwood","year":"2016","journal-title":"Health Aff"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"e20173459","DOI":"10.1542\/peds.2017-3459","article-title":"Prevalence of obesity and severe obesity in US children, 1999\u20132016","volume":"141","author":"AC Skinner","year":"2018","journal-title":"Pediatrics"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pbb.2011.02.013","article-title":"Abnormalities in parentally rated executive function in methamphetamine\/polysubstance exposed children","volume":"98","author":"BJ Piper","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/02791072.2016.1260187","article-title":"To study, to party, or both? Assessing risk factors for non-prescribed stimulant use among middle and high school students","volume":"49","author":"KS Le\u00f3n","year":"2017","journal-title":"J Psychoactive Drugs"},{"key":"ref50","author":"LD Johnston","year":"2018"},{"key":"ref51","year":"2017"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3109\/15563650.2015.1027903","article-title":"Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers","volume":"53","author":"ME Kaland","year":"2015","journal-title":"Clin Toxicol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants-United States, 2015\u20132016","volume":"67","author":"P Seth","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.healthpol.2010.03.005","article-title":"The discrepancy in attention deficit hyperactivity disorder (ADHD) medications diffusion: 1994-2003-a global pharmaceutical data analysis","volume":"97","author":"HC Lang","year":"2010","journal-title":"Health Policy"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.15288\/jsad.2016.77.556","article-title":"Use and misuse of opioids in Maine: Results from pharmacists, the prescription monitoring, and the diversion alert programs","volume":"77","author":"BJ Piper","year":"2016","journal-title":"J Stud Alcohol Drugs"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1521\/adhd.2005.13.3.5","article-title":"Medication treatment of ADHD in Latino\/Hispanic children","volume":"13","author":"JJ Bauermeister","year":"2005","journal-title":"The ADHD Report"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/jcpp.12170","article-title":"The association of attention deficit hyperactivity disorder with socioeconomic disadvantage: alternative explanations and evidence","volume":"55","author":"G Russell","year":"2014","journal-title":"J Child Psychol Psychiatry"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12887-017-0971-0","article-title":"Challenges in defining the rates of ADHD diagnosis and treatment: Trends over the last decade","volume":"17","author":"M Davidovitch","year":"2017","journal-title":"BMC Pediatr"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jama.2018.1150","article-title":"Health care spending in the United States and other high-income countries","volume":"319","author":"I Papanicolas","year":"2018","journal-title":"JAMA"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1089\/cap.2014.0020","article-title":"Cardiovascular safety of stimulants in children with Attention-Deficit\/Hyperactivity Disorder: A nationwide prospective cohort study","volume":"24","author":"S Dalsgaard","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref61","first-page":"495","article-title":"Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny","volume":"19","author":"MN Strawn","year":"2003","journal-title":"J Contemp Health Law Policy"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/NMD.0b013e318257c4b6","article-title":"DSM-5 further inflates Attention Deficit Hyperactivity Disorder","volume":"200","author":"L Batstra","year":"2012","journal-title":"J Nerv Ment Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1521\/adhd.12.6.8.55256","article-title":"An investigation of reported symptoms of ADHD in a university population","volume":"12","author":"AG Harrison","year":"2004","journal-title":"The ADHD Report"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1521\/adhd.2006.14.4.1","article-title":"Adults faking ADHD: You must be kidding!","volume":"14","author":"AG Harrison","journal-title":"The ADHD Report"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.acn.2007.03.008","article-title":"Identifying students faking ADHD: Preliminary findings and strategies for detection","volume":"22","author":"AG Harrison","year":"2007","journal-title":"Ach Clin Neuropsychol"},{"key":"ref66","first-page":"6","article-title":"Comparison of ease of falsification of Attention Deficit Hyperactivity Disorder diagnosis using standard behavioral rating scales","volume":"2","author":"G Jachimowicz","year":"2004","journal-title":"Cognitive Science Online"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1080\/13854046.2011.630024","article-title":"Using symptom validity tests to detect malingered ADHD in college students","volume":"25","author":"LJ Jasinski","year":"2011","journal-title":"Clin Neuropsychol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1037\/pas0000435","article-title":"Intentional inattention: Detecting feigned attention-deficit\/hyperactivity disorder on the Personality Assessment Inventory","volume":"29","author":"ST Smith","year":"2017","journal-title":"Psychol Assess"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1037\/a0018857","article-title":"Detection of feigned ADHD in college students","volume":"22","author":"MJ Sollman","year":"2010","journal-title":"Psych Assess"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.15171\/ijhpm.2017.124","article-title":"Trade agreements and direct-to-consumer advertising of pharmaceuticals","volume":"7","author":"D Gleeson","year":"2018","journal-title":"Int J Health Policy Manag"},{"key":"ref71","year":"2015"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/appi.ajp.2011.11060940","article-title":"Striatal dopamine transporter alterations in ADHD: Pathophysiology or adaptation to psychostimulants? A meta-analysis","volume":"169","author":"P Fusar-Poli","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/104454601750143366","article-title":"Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters","volume":"11","author":"GH Moll","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1749-6632.2009.05148.x","article-title":"Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse","volume":"1187","author":"KC Schmitt","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bcp.2013.04.013","article-title":"Adolescence methylphenidate treatment in a rodent model of attention deficit\/hyperactivity disorder: Dopamine transporter function and cellular distribution in adulthood","volume":"86","author":"SS Somkuwar","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamapsychiatry.2016.1182","article-title":"Safer, DJ. Trends in stimulant medication use in commercially insured youths and adults, 2010\u20132014","volume":"73","author":"M Burcu","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/1087054715605915","article-title":"Recent trends in stimulant usage","volume":"20","author":"DJ Safer","year":"2016","journal-title":"J Attention Dis"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1542\/peds.2014-1778","article-title":"Overdiagnosis: how our compulsion for diagnosis may be harming children","volume":"134","author":"ER Coon","year":"2014","journal-title":"Pediatrics"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"c547","DOI":"10.1136\/bmj.c547","article-title":"Is ADHD a valid diagnosis in adults?","volume":"340","author":"J Moncrieff","year":"2010","journal-title":"No. BMJ"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/070674371506000705","article-title":"Is adult Attention-Deficit Hyperactivity Disorder being overdiagnosed?","volume":"60","author":"J Paris","year":"2015","journal-title":"Can J Psychiatry"},{"issue":"3","key":"ref81","doi-asserted-by":"crossref","first-page":"e20160407","DOI":"10.1542\/peds.2016-0407","article-title":"Racial and ethnic disparities in ADHD diagnosis and treatment","volume":"138","author":"TR Coker","year":"2016","journal-title":"Pediatrics"},{"key":"ref82","first-page":"1","article-title":"A warning sign on the road to the DSM-5: Beware of its unintended consequences","author":"A Frances","year":"2009","journal-title":"Psychiatric Times"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.4088\/JCP.16m10884","article-title":"Differential risk of increasing psychotropic polypharmacy use in children diagnosed with ADHD as preschoolers","volume":"78","author":"AG Winterstein","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugpo.2016.04.020","article-title":"Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets","volume":"35","author":"J Aldridge","year":"2016","journal-title":"Int J Drug Policy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:23:49Z","timestamp":1589027029000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206100"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,28]]},"references-count":84,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206100","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,28]]}}}